Definium Soars As Much As 50% After LSD-Based Depression Drug Meets Late-Stage Clinical Trial Goal
--------------------------------------------------------------------
Source: Zero Hedge
Published: 2026-06-23 05:45 UTC+10:00
Section: General
Factuality Score: 92
Opinion Category: Neutral
Topics: Business, Science, Health, Law & Courts, Drugs, Crime & Justice
--------------------------------------------------------------------
Snippet:
Definium Therapeutics shares surged as much as 54% on Monday, reaching $37.90 in morning trading as investors reacted positively to developments in the biotech company's research pipeline and potential strategic opportunities.
--------------------------------------------------------------------